The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYSX | 13.09 | 0.07 | +0.54% |
| NYLI Candriam Emerging Markets Eq Cl R6 | |||
| GSRCX | 11.18 | 0.05 | +0.45% |
| Goldman Sachs Rising Dividend Gr C | |||
| GSPKX | 18.31 | 0.05 | +0.27% |
| Goldman Sachs US Eq Div and Prem Instl | |||
| FESGX | 77.05 | 0.12 | +0.16% |
| First Eagle Global C | |||
| NRIIX | 22.43 | 0.03 | +0.13% |
| Nuveen Real Asset Income I | |||
A.I.dvisor indicates that over the last year, PNOTX has been closely correlated with FSMAX. These tickers have moved in lockstep 97% of the time. This A.I.-generated data suggests there is a high statistical probability that if PNOTX jumps, then FSMAX could also see price increases.
| Ticker / NAME | Correlation To PNOTX | 1D Price Change % | ||
|---|---|---|---|---|
| PNOTX | 100% | +0.16% | ||
| FSMAX - PNOTX | 97% Closely correlated | N/A | ||
| RPTIX - PNOTX | 83% Closely correlated | +0.15% | ||
| RPMGX - PNOTX | 83% Closely correlated | +0.15% | ||
| PAMCX - PNOTX | 83% Closely correlated | +0.14% | ||
| RRMGX - PNOTX | 82% Closely correlated | +0.15% | ||
More | ||||